Proinflammatory Cytokines: Possible Accomplices for the Systemic Effects of Clostridioides difficile Toxin B
Open Access
- 1 January 2021
- journal article
- research article
- Published by Taylor & Francis Ltd in Journal of Inflammation Research
- Vol. ume 14, 57-62
- https://doi.org/10.2147/jir.s287096
Abstract
Clostridioides difficile infection (CDI) has a serious impact on the healthcare system, and most of its pathogenic effects are mainly due to the activity of toxins A and B (TcdA and TcdB, respectively). The molecular mechanisms of their cytotoxic activity are well known, especially in the colon, where the infection occurs and normally remains localized. However, the mechanisms causing toxic effects on various systemic organs (extraintestinal manifestations) with frequent lethal outcomes in some patients affected by CDI are still poorly understood. Few studies are available that demonstrate low serum levels of Tcds in both experimental animal models and patients with CDI. Until now, it has remained unclear how low levels of circulating Tcds could lead to serious toxic effects. On the basis of our previous in vitro studies, in which the proinflammatory cytokines TNF-alpha and IFN-gamma strongly potentiated the toxic activity of low doses of TcdB, we hypothesize that the presence of both TcdB in the circulation and a systemic proinflammatory cytokine storm may be responsible for the selective severe effects of TcdB in some patients. This may occur in patients with severe CDI and systemic Tcds, in whom proinflammatory cytokines such as TNF-alpha and IFN-gamma reach a significant concentration in the circulation. This hypothesis could identify therapeutic interventions based on the reduction or neutralization of the indirect toxic action of these cytokines.Keywords
This publication has 57 references indexed in Scilit:
- Mortality in patients with Clostridium difficile infection correlates with host pro-inflammatory and humoral immune responsesJournal of Medical Microbiology, 2013
- Toward a structural understanding of Clostridium difficile toxins A and BFrontiers in Cellular and Infection Microbiology, 2012
- Systemic Dissemination of Clostridium difficile Toxins A and B Is Associated With Severe, Fatal Disease in Animal ModelsThe Journal of Infectious Diseases, 2011
- Primary Human Colonic Myofibroblasts Are Resistant to Clostridium difficile Toxin A-Induced, but Not Toxin B-Induced, Cell DeathInfection and Immunity, 2011
- Inhibition of Rho–ROCK signaling induces apoptotic and non-apoptotic PS exposure in cardiomyocytes via inhibition of flippaseJournal of Molecular and Cellular Cardiology, 2010
- Clostridium difficileBacteremia, Taiwan1Emerging Infectious Diseases, 2010
- The Enterotoxicity of Clostridium difficile ToxinsToxins, 2010
- Clostridium difficileToxins: Mechanism of Action and Role in DiseaseClinical Microbiology Reviews, 2005
- Caspase-independent cell death in T lymphocytesNature Immunology, 2003
- Extracolonic Manifestations of Clostridium difficile InfectionsMedicine, 2001